Physicians Deserve Timely Authoritative Risk Information For Medicines
16 March 2015
A Washington Post article today inaccurately describes the Food and Drug Administration’s (FDA) proposed guidance on distributing peer-reviewed scientific and medical information to healthcare professionals.
China drug approval backlog jumped by a third last year
16 March 2015
China had more than 18,500 drugs waiting for approval at the end of 2014, up by a third from a year before, the official Center for Drug Evaluation said on Friday, reflecting industry concern that it is getting harder to get medicines approved in the China market.
New market for liver disease spawns race for better testing
16 March 2015
As drugmakers develop new medicines to battle a liver disease epidemic, they have created an urgent need for better diagnostics to select patients for treatment and assess their drugs' effectiveness.
GAO report blames DEA for many drug shortages
16 March 2015
Secondary trading environment critical for small businesses
16 March 2015
Emerging companies are considered to be the drivers of U.S. economic activity, innovation and job creation. Their ability to survive and prosper depends on ready access to capital, particularly in the private markets
Watchdog groups decry FDA's move to let reps hand out journal articles
13 March 2015
Little did the FDA know that allowing drugmakers to hand out medical-journal articles to doctors would be so controversial. After talking about the idea for years--since 2007, at least--the agency rolled out some guidelines last June that would govern the practice. And now, the consumer watchdogs at Public Citizen, along with a bevy of patient groups, are in full protest mode.
Don’t edit the human germ line
13 March 2015
It is thought that studies involving the use of genome-editing tools to modify the DNA of human embryos will be published shortly.
Return to pre-antibiotic era? AMR hits developing countries hardest
13 March 2015
New antibiotic agents are urgently needed to overcome the burgeoning problem of antimicrobial resistance (AMR) in infectious bacteria, but novel agents alone may not be sufficient to prevent a return to the dark days of the pre-antimicrobial era, an infectious disease specialist has warned.
Building a viable U.S. market is the next big quest for biosimilars
13 March 2015
While the FDA may have opened the biosimilar pipeline with its approval of Sandoz Inc.'s Zarxio Friday, a lot of heavy lifting has to be done before biosimilars are a viable market in the U.S.
Marinus Pharmaceuticals Provides Business Update and Reports Year End 2014 Financial Results
12 March 2015
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative epilepsy and other neuropsychiatric therapeutics, today provided a business update and announced its financial results for the year ended December 31, 2014.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024